Cleared Traditional

K912804 - FSH IRMA IMMUNOMAG

K912804 is an FDA 510(k) clearance for FSH IRMA IMMUNOMAG, manufactured by Pantex, Div. Bio-Analysis, Inc.. The device is a Class 1 Chemistry device with product code CGJ cleared through the Traditional 510(k) pathway after a 48-day FDA review.

K912804 · Pantex, Div. Bio-Analysis, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1991
Decision
48d
Days
Class 1
Risk

K912804 is an FDA 510(k) clearance for the FSH IRMA IMMUNOMAG. Classified as Radioimmunoassay, Follicle-stimulating Hormone (product code CGJ), Class I - General Controls.

Submitted by Pantex, Div. Bio-Analysis, Inc. (Santa Monica, US). The FDA issued a Cleared decision on August 12, 1991 after a review of 48 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1300 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pantex, Div. Bio-Analysis, Inc. devices

FDA 510(k) Submission Details - K912804

510(k) Number K912804 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 25, 1991
Decision Date August 12, 1991
Days to Decision 48 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 88d · This submission: 48d
Pathway characteristics
Predicate-based equivalence.

CGJ Device Classification - Class 1, General Controls

Product Code CGJ Radioimmunoassay, Follicle-stimulating Hormone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1300
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CGJ Radioimmunoassay, Follicle-stimulating Hormone

All 68
Devices cleared under the same product code (CGJ) and FDA review panel - the closest regulatory comparables to K912804.
COBAS CORE FSH EIA
K930304 · Roche Diagnostic Systems, Inc. · Sep 1993
VITEK IMMUNODIAGNOSTIC ASSAY SYSTEM
K921746 · Biomerieux Vitek, Inc. · Jun 1992
FSH ENZYME IMMUNASSAY TEST KIT NO:KIF4057
K915208 · Medix Biotech, Inc. · Dec 1991
OPUS FSH
K911409 · Pb Diagnostic Systems, Inc. · Apr 1991
AFFINITY FSH TEST SYSTEM
K905592 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Dec 1990
CIBA CORNING ACS FSH IMMUNOASSAY
K904649 · Ciba Corning Diagnostics Corp. · Nov 1990